Delivery Order SPE2DB20D2104-SPE2DB25FMVQC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units, valued at $7,315.22. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract calls for delivery by August 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a anticoagulant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $9,066.65. This firm fixed-price delivery order, with an ultimate completion date of June 12, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely prescribed anticoagulant medication used in military and veteran...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $12,260.04. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for completion by May 13, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $14,301.29. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 23, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Eliquis is...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging). This firm fixed-price contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is non-set-aside and was competitively awarded, with a place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) at a ceiling value of $1,556.10. This contract represents a firm fixed price delivery order under a non-set-aside competitive procurement and is scheduled for ultimate completion on August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a prescription...
- On July 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). The contract, executed on a firm fixed-price basis with no set-aside designation, is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order through its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order valued at $17,793.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.53 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veterans' healthcare...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVQCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packaging) with a contract ceiling value of $1,965.60. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract was completed on July 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare systems to prevent blood clots and reduce stroke risk. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally, including specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic categories. The company's federal contracting history demonstrates consistent capability in meeting DLA requirements through competitive procurement and delivering products critical to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/16/25 |